• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Is BRAF V600E Mutation Associated with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma?

作者信息

Lai Hon-Fan, Hang Jen-Fan, Chen Jui-Yu

机构信息

Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.

School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China.

出版信息

Ann Surg Oncol. 2024 Jun;31(6):3974-3975. doi: 10.1245/s10434-024-15058-6. Epub 2024 Feb 16.

DOI:10.1245/s10434-024-15058-6
PMID:38366182
Abstract
摘要

相似文献

1
ASO Author Reflections: Is BRAF V600E Mutation Associated with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma?ASO作者反思：BRAF V600E突变与甲状腺乳头状癌较差的临床预后相关吗？
Ann Surg Oncol. 2024 Jun;31(6):3974-3975. doi: 10.1245/s10434-024-15058-6. Epub 2024 Feb 16.
2
Letter to the Editor: Comment on: "BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma".致编辑的信：对“BRAF V600E突变与甲状腺乳头状癌较差临床预后无关”的评论
Ann Surg Oncol. 2024 Jun;31(6):3737-3738. doi: 10.1245/s10434-024-15225-9. Epub 2024 Mar 21.
3
Incidence of V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience.甲状腺乳头状癌患者中V600E突变的发生率：单机构经验
J Int Med Res. 2019 Nov;47(11):5560-5572. doi: 10.1177/0300060519873481. Epub 2019 Sep 18.
4
BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma.BRAF V600E 突变与致癌突变共存与甲状腺乳头状癌侵袭性临床病理特征和不良预后相关。
Asian J Surg. 2024 Jan;47(1):413-419. doi: 10.1016/j.asjsur.2023.09.049. Epub 2023 Sep 24.
5
Evaluation of the expression levels of BRAF mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay.应用超敏突变检测法评估甲状腺癌原发灶中 BRAF mRNA 的表达水平。
BMC Cancer. 2020 May 1;20(1):368. doi: 10.1186/s12885-020-06862-w.
6
[The co-relation of BRAF V600E mutation and factors affecting occurrence and prognosis of papillary thyroid carcinoma].[BRAF V600E突变与影响甲状腺乳头状癌发生及预后因素的相关性]
Zhonghua Bing Li Xue Za Zhi. 2019 Apr 8;48(4):288-292. doi: 10.3760/cma.j.issn.0529-5807.2019.04.005.
7
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.细针抽吸细胞学检查甲状腺乳头状癌时 BRAF V600E 基因突变呈假阴性。
World J Surg Oncol. 2017 Nov 13;15(1):202. doi: 10.1186/s12957-017-1266-5.
8
The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.BRAF V600E突变作为甲状腺乳头状癌预后分层潜在标志物的作用：一项长期随访研究
Endocr Res. 2014;39(4):189-93. doi: 10.3109/07435800.2013.879169. Epub 2014 Mar 28.
9
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients.日本人群中甲状腺乳头状癌的BRAF突变：其与高危临床病理特征及患者无病生存期缺乏相关性
Endocr J. 2009;56(1):89-97. doi: 10.1507/endocrj.k08e-208. Epub 2008 Oct 8.
10
An Animal Model Further Uncovers the Role of Mutant Braf during Papillary Thyroid Cancer Development.一种动物模型进一步揭示了突变型 Braf 在甲状腺乳头状癌发展过程中的作用。
Am J Pathol. 2020 Mar;190(3):702-710. doi: 10.1016/j.ajpath.2019.11.006. Epub 2020 Jan 14.

引用本文的文献

1
Optimizing Preoperative Rehabilitation: Shaping the Future of Lung Cancer Surgery Outcomes.优化术前康复：塑造肺癌手术预后的未来。
Ann Surg Oncol. 2025 Jan;32(1):30-32. doi: 10.1245/s10434-024-16256-y. Epub 2024 Sep 17.
2
Letter to the Editor: Comment on: "BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma".致编辑的信：对“BRAF V600E突变与甲状腺乳头状癌较差临床预后无关”的评论
Ann Surg Oncol. 2024 Jun;31(6):3737-3738. doi: 10.1245/s10434-024-15225-9. Epub 2024 Mar 21.

本文引用的文献

1
Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.BRAF V600E 突变是否预示甲状腺乳头癌的侵袭性特征？来自四个内分泌外科中心的研究结果。
J Clin Endocrinol Metab. 2013 Sep;98(9):3702-12. doi: 10.1210/jc.2013-1584. Epub 2013 Aug 22.
2
The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.BRAF(V600E) 突变与甲状腺乳头癌预后因素及不良临床结局的相关性：一项荟萃分析。
Cancer. 2012 Apr 1;118(7):1764-73. doi: 10.1002/cncr.26500. Epub 2011 Aug 31.
3
Observer variation of encapsulated follicular lesions of the thyroid gland.
甲状腺滤泡性包封性病变的观察者间差异。
Am J Surg Pathol. 2002 Nov;26(11):1508-14. doi: 10.1097/00000478-200211000-00014.